Tranexamic acid use during coronary artery bypass grafting.
Rubens
F
F
Wells
P
P
D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D016009:Chi-Square Distribution; D001026:Coronary Artery Bypass / Q000379:methods*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D014148:Tranexamic Acid / Q000494:pharmacology / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D005341:Fibrinolysin